23.30
Schlusskurs vom Vortag:
$24.09
Offen:
$23.97
24-Stunden-Volumen:
363.38K
Relative Volume:
1.38
Marktkapitalisierung:
$1.04B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+10.66%
1M Leistung:
+62.82%
6M Leistung:
+283.03%
1J Leistung:
+0.00%
Septerna Inc Stock (SEPN) Company Profile
Firmenname
Septerna Inc
Sektor
Branche
Telefon
650-338-3533
Adresse
250 EAST GRAND AVENUE, SUITE 65, SOUTH SAN FRANCISCO
Vergleichen Sie SEPN mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
SEPN
Septerna Inc
|
23.30 | 1.07B | 0 | 0 | 0 | 0.00 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Septerna Inc Stock (SEPN) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-06-23 | Eingeleitet | H.C. Wainwright | Buy |
2025-02-18 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
2024-11-19 | Eingeleitet | Cantor Fitzgerald | Overweight |
2024-11-19 | Eingeleitet | JP Morgan | Overweight |
2024-11-19 | Eingeleitet | TD Cowen | Buy |
2024-11-19 | Eingeleitet | Wells Fargo | Overweight |
Alle ansehen
Septerna Inc Aktie (SEPN) Neueste Nachrichten
Is Septerna Inc. stock a safe haven assetMarket Trend Review & Free Technical Confirmation Trade Alerts - newser.com
Septerna Inc. stock trend outlook and recovery path2025 EndofYear Setup & AI Enhanced Execution Alerts - newser.com
Will Septerna Inc. rebound enough to break evenJuly 2025 Snapshot & Free High Accuracy Swing Entry Alerts - newser.com
Can technical indicators confirm Septerna Inc.’s reversalJuly 2025 Reactions & Free Daily Entry Point Trade Alerts - newser.com
Multi asset correlation models including Septerna Inc.2025 Stock Rankings & Free Verified High Yield Trade Plans - newser.com
How hedge fund analytics apply to Septerna Inc. stockEarnings Trend Report & Weekly High Return Forecasts - newser.com
Is Septerna Inc. stock bottoming out2025 Trading Volume Trends & Daily Chart Pattern Signal Reports - newser.com
Septerna Inc. stock trend forecast2025 Performance Recap & Advanced Swing Trade Entry Plans - newser.com
Momentum divergence signals in Septerna Inc. chartJuly 2025 Summary & Community Verified Swing Trade Signals - newser.com
Septerna (NASDAQ:SEPN) Shares Gap DownHere's Why - MarketBeat
Will Septerna’s (SEPN) Latest Board Appointment Strengthen Its R&D Edge or Reinforce the Status Quo? - simplywall.st
Septerna, Inc. (SEPN) Stock Report: Exploring a 4.8% Potential Upside Amidst Biotech Innovations - DirectorsTalk Interviews
Using data tools to time your Septerna Inc. exitMarket Performance Report & Real-Time Buy Zone Alerts - newser.com
Septerna Inc Stock Analysis and ForecastEarnings Beat Highlights & Maximize Gains Professionally - earlytimes.in
What drives Septerna Inc stock priceTechnical Breakout Signals & Outperform With Our Smart Trading Calculator - earlytimes.in
Septerna (SEPN): Evaluating Valuation Following Dr. Keith Gottesdiener’s Board Appointment - Yahoo Finance
Strength Seen in Septerna, Inc. (SEPN): Can Its 7.0% Jump Turn into More Strength? - Yahoo Finance
Visual analytics tools that track Septerna Inc. performancePortfolio Growth Summary & Free Risk Controlled Daily Trade Plans - newser.com
Weiss Ratings Reaffirms "Sell (D-)" Rating for Septerna (NASDAQ:SEPN) - MarketBeat
Price momentum metrics for Septerna Inc. explainedGold Moves & Short-Term Trading Alerts - newser.com
How Septerna Inc. stock performs in high volatility markets2025 Winners & Losers & Daily Profit Focused Screening - newser.com
A Look at Septerna’s (SEPN) Valuation Following Board Appointment of Veteran R&D Leader - Sahm
Septerna (NASDAQ:SEPN) Shares Up 8.5%Should You Buy? - MarketBeat
Septerna plunges as safety concerns force an end to early-stage trial - MSN
Real time breakdown of Septerna Inc. stock performanceJuly 2025 Reactions & Consistent Income Trade Recommendations - newser.com
Is Septerna Inc. stock entering bullish territory2025 Winners & Losers & Long-Term Growth Plans - newser.com
Septerna, Inc. (NASDAQ:SEPN) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
We're Not Worried About Septerna's (NASDAQ:SEPN) Cash Burn - Sahm
Are Options Traders Betting on a Big Move in Septerna Stock? - Yahoo Finance
Can Septerna Inc. stock hit analyst price targetsJuly 2025 Highlights & Entry Point Confirmation Signals - newser.com
Using RSI to spot recovery in Septerna Inc.Quarterly Risk Review & Long-Term Capital Growth Strategies - newser.com
Septerna Up 12%, Insider Buyers Are Up 219% - Yahoo Finance
Septerna appoints Keith Gottesdiener to board of directors By Investing.com - Investing.com Nigeria
Septerna Begins Phase 1 Trial for SEP-631 - MSN
Septerna, Inc. Expands Board with New R&D Chair - TipRanks
Septerna appoints Keith Gottesdiener to board of directors - Investing.com India
Finanzdaten der Septerna Inc-Aktie (SEPN)
Es liegen keine Finanzdaten für Septerna Inc (SEPN) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):